Triterpenoids and Lignans From Schisandra henryi subsp. yunnanensis A. C. Smith. [PDF]
Cao YY, Hu K, Li XN, Sun HD, Puno PT.
europepmc +1 more source
<i>Schisandra chinensis</i> Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease. [PDF]
Wang LJ +8 more
europepmc +1 more source
Pharmacological Effects and Molecular Mechanisms of Lignans in the Treatment of Alzheimer's Disease. [PDF]
Sun L +7 more
europepmc +1 more source
Modulation of disease-associated gut microbiota by <i>Schisandra chinensis</i>: a literature review. [PDF]
Liu Z +5 more
europepmc +1 more source
Bacteriostatic Mechanism of the Ethyl Acetate Extract from the Root of <i>Schisandra propinqua</i> (Wall.) Baill. var. <i>sinensis</i> Oliv (Xiao Xue Teng) Against <i>Staphylococcus aureus</i>. [PDF]
Gu L +6 more
europepmc +1 more source
Integrating Network Pharmacology and Metabolomics to Decipher the Mechanisms Underlying the Therapeutic Effects of Wuzhi Dripping Pills Against MASLD. [PDF]
Wang H +6 more
europepmc +1 more source
Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis. [PDF]
Tang T, Li G, Huang X, Liang H.
europepmc +1 more source
Ameliorative Effects of Schisandrol A on Lipopolysaccharide-Induced Intestinal Injury in Mice. [PDF]
Wang X +6 more
europepmc +1 more source
Characterization, Identification, and Antioxidant Mechanism of Antioxidant Peptides From <i>Schisandra chinensis</i> Based on Peptidome and Molecular Docking/Dynamics. [PDF]
Zheng S +7 more
europepmc +1 more source
<i>Schisandra chinensis</i> alleviates Hypertriglyceridemia in nonalcoholic fatty liver disease by modulating the gut microbiota and hepatic lipid metabolism: identification of its active fractions. [PDF]
Li Q +5 more
europepmc +1 more source

